Bill

Bill > S04664


NY S04664

NY S04664
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders.


summary

Introduced
02/11/2025
In Committee
01/07/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT in relation to to directing the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder

AI Summary

This bill directs the New York State Commissioner of Health, in collaboration with the Commissioners of Mental Health and Veterans' Services, to conduct a comprehensive study on ibogaine - a naturally occurring psychoactive substance - as a potential treatment for post-traumatic stress disorder (PTSD), which is increasingly diagnosed among veterans and first responders. The study will specifically investigate the possible medical benefits and risks, as well as assess the appropriateness and effectiveness of ibogaine in treating PTSD. The commissioners are required to submit a detailed report with their findings and recommendations to the governor, legislative leaders, and all members of the New York State Legislature within one year of the act's effective date. By mandating this research, the bill aims to explore alternative treatment options for individuals suffering from PTSD, a serious mental health condition commonly experienced by those in high-stress, traumatic professions like military service and emergency response.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

REFERRED TO HEALTH (on 01/07/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...